Recent

% | $
Quotes you view appear here for quick access.

Genomic Health Inc. Message Board

mdwhittier 129 posts  |  Last Activity: Apr 24, 2015 6:03 PM Member since: Sep 17, 2012
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    zero yet?

    by jonkellyzrich Jan 27, 2015 12:01 PM
    mdwhittier mdwhittier Jan 27, 2015 1:28 PM Flag

    Who's making peanuts posting under dozens of ever changing ID's on multiple threads? That would be YOU!
    Just another ID of yours on ignore. You're more fun than whack-a-mole! LOL

    Sentiment: Strong Buy

  • mdwhittier mdwhittier Jan 28, 2015 10:39 PM Flag

    What's your time horizon? Can you afford to hold shares for 2 years, even if the stock prices falls to $35 in the next few months? This is a co. that will have at least 7 targets in the clinic by year's end. If you are holding out for $50. you need to think much bigger, like $150 share. But you'll need to have at least a 2-3 year time horizon. That would be a very decent return on your investment. The biggest mistake I've made in biotech is selling too soon for a quick 20% return. I can't tell you the number of stocks I wish I had held on to, but took a quick profit instead. Forget about the volatility. Put this one away and don't obsess over the weekly fluctuations. And don't sell too soon, you'll regret it later. Remember, let your winners run. GLTA

    Sentiment: Buy

  • Reply to

    Kite is a scam

    by stocksarerigged Jan 23, 2015 10:46 AM
    mdwhittier mdwhittier Jan 29, 2015 11:21 AM Flag

    stocksarerigged knows nada about Kite; just a paid shill.

    Sentiment: Strong Buy

  • Reply to

    I am ready to make friends

    by simp08801 Jan 30, 2015 9:22 AM
    mdwhittier mdwhittier Jan 30, 2015 3:38 PM Flag

    The Feds were looking at all possible angles with different drug/vaccine interventions. The one that appealed to them the most, for the long haul, was a vaccine, since Ebola isn't a first world problem. Probably the biggest issue with Srpt's treatment was its administration route; IV only. If there had been more outbreaks in the U.S. the scenario for Srpt's Ebola tx might have had a different outcome.

    Sentiment: Strong Buy

  • Reply to

    broke yet bagholderz?

    by jonubrokefukerkellyz Jan 30, 2015 2:34 PM
    mdwhittier mdwhittier Jan 30, 2015 4:07 PM Flag

    Whack-A-Mole! Adios

    Sentiment: Strong Buy

  • Reply to

    One more from Mindy

    by thigrlsrk Jan 29, 2015 6:29 PM
    mdwhittier mdwhittier Jan 30, 2015 4:11 PM Flag

    Seriously, you owned medx and didn't sell it when it went to $200 a share? You're clearly a poser. And back on ignore.

    Sentiment: Strong Buy

  • Reply to

    dear simp

    by qpoint617 Jan 30, 2015 8:47 AM
    mdwhittier mdwhittier Jan 31, 2015 6:04 PM Flag

    Oh I see, there are true believers, living in the dumpster of false hope, while the savvy street pros have the true insight, and are standing in the light, relative to divining Srpt's future. Admittedly, the false hope longs believed the initial FDA verbiage about the small N not being a huge barrier to AA. Clearly, the FDA does not always mean what it says, and it appears it was just trying to pacify the parents, sadly giving them false hope also.

    While the data has certainly been encouraging, the FDA wants to say they approved Etep. for all the right, evidenced based reasons; we're not there yet. When additional positive data accumulates to the point of critical mass, with dystrophin data being the key, the buying spree won't be "prolonged". If the dystrophin data by 3 independent labs is positive, the shorts will be rushing to cover their positions. Shorts continuing to hold their positions at this stage are just greedy; easy come, easy go.

    Sentiment: Strong Buy

  • Reply to

    what happened ?

    by mantel99 Feb 3, 2015 10:49 AM
    mdwhittier mdwhittier Feb 3, 2015 1:46 PM Flag

    The perception is that Car-T / gene-therapy stock valuations had gotten stretched, and now the re-valuation is happening. Usually, in biotech land, the correction overshoots to the downside. These stocks are just wild beta stocks, and will continue to be so in the absence of any significant news. It's tough to hold in this environment, but if your time horizon is at least 2 years, there's a good chance of a double from here, imo. GLTA

  • Reply to

    what happened ?

    by mantel99 Feb 3, 2015 10:49 AM
    mdwhittier mdwhittier Feb 4, 2015 12:49 PM Flag

    I feel your pain, as I have been burned more than a few times in the biotech space. Yes, the hype was on max volume back in Dec. A lot of promotional activity wrt to car-t / gene therapy stocks. The thing to keep in mind is the disruptive nature of drug therapy here. Kite's car-t treatment works. The treatment is still being refined for certain types of blood cancer, but the pipeline of drug candidates is fairly compelling. Biotech land has always been extremely volatile, and will continue to be so. If you've sold, keep an eye on Kite; it's always possible there will be a lower/better entry point. Unless some positive news emerges, which you can never rule out.

    Sentiment: Hold

  • mdwhittier mdwhittier Feb 5, 2015 2:10 PM Flag

    Tainted? I think it's fair to say he angered the FDA gods. But due to the FDA's lack of clarity about future trial designs, flip-flopping about requirements for AA, and horribly delayed response to questions about dystrophin quantitation, confirmatory trials were unnecessarily delayed. Let's not put it all on C.G. - that's just misplaced blame. Easier to target and blame one person, rather than an agency that operates in an arena that is less than transparent.

    Sentiment: Strong Buy

  • Reply to

    srpt ebola opp is dead

    by simp08801 Feb 6, 2015 8:27 AM
    mdwhittier mdwhittier Feb 6, 2015 10:16 AM Flag

    Lame pronouncement, simp. What makes you the final authority on whether or not srpt's anti-viral program takes flight in the future?

    Sentiment: Strong Buy

  • Reply to

    You can't fix his reputation

    by starfe11 Feb 6, 2015 3:17 PM
    mdwhittier mdwhittier Feb 6, 2015 4:26 PM Flag

    Don't think parents of DMD kids would agree with you. Their opinion is WAY more important than yours.

    Sentiment: Strong Buy

  • mdwhittier mdwhittier Feb 12, 2015 11:09 AM Flag

    "hes worthless and a major negative force"......hmmm....no, that would be you, starfe11.

  • Reply to

    Today's Event

    by georgecantstansya Feb 11, 2015 10:45 AM
    mdwhittier mdwhittier Feb 12, 2015 2:18 PM Flag

    Typically, the payor for the medical procedure retains rights to the clinical results, and may disclose the results to the patient at their discretion.

  • Reply to

    PFNX undervalued, new PT $50

    by jderecruit Feb 12, 2015 1:07 PM
    mdwhittier mdwhittier Feb 13, 2015 2:08 PM Flag

    140k print buy today at $12.65. Now that's confidence by a hedge or mutual fund.

    Sentiment: Strong Buy

  • Reply to

    Starfe 11

    by kevinb2120l2 Feb 13, 2015 12:45 PM
    mdwhittier mdwhittier Feb 13, 2015 3:48 PM Flag

    Maybe he'll consider getting on some meds for O.C.D. We can only hope. He's a huge polluter of the mb.

    Sentiment: Strong Buy

  • Reply to

    why are some on srpt mb so ?

    by saintthomas671 Feb 23, 2015 5:56 PM
    mdwhittier mdwhittier Feb 23, 2015 10:44 PM Flag

    Well said, sir. The reverse split, while elevating the share price, hasn't done much for a lot of long-suffering longs. It's been a wild ride the past 3 years, with not much to show for the investment, given the historic rise of the biotech ETF/iShares investment landscape. There are many cases in the world of biotech where a stock seemingly went nowhere for 3 years, and then all the stars aligned; the clinical trials were conducted to the satisfaction of FDA, clinical benefit found to be valid with appropriate dosing, and in due time approval came in, resulting in eventual buy-out by large pharma. I think that's SRPT. In 1 more year this investment has the great potential to be at least a 5 bagger. It's just a shame that DMD boys have been denied a drug that is safe, and given early enough, can likely prevent muscle fibrosis, and all the eventual physical / medical complications that result from that. The idea of selling SRPT for $20 is pathetic capitulation psychology. Being long sometimes means a 3-5 year time horizon. GLTA

    Sentiment: Strong Buy

  • Reply to

    Back to the 12s?

    by winterlion7722 Feb 24, 2015 10:46 AM
    mdwhittier mdwhittier Feb 24, 2015 11:11 AM Flag

    When you consider the share price was up nearly 30% in just a tad over 3 weeks, I think this is just traders ringing the cash register. I've noticed a number of bio-techs today that are off a similar % amount; ones that have had recent runs. We'll only see the 12's again if there's a major market correction.

    Sentiment: Strong Buy

  • Reply to

    Winter ...

    by simp08801 Feb 24, 2015 3:51 PM
    mdwhittier mdwhittier Feb 24, 2015 7:25 PM Flag

    Yep, I'm with you. Their biases are out there for all to see, once you listen to the webcast. Talk about drinking your own Kool Aid. Simp and Winter are passing the cup between themselves.

    Sentiment: Strong Buy

GHDX
30.59-0.29(-0.94%)Apr 24 4:00 PMEDT